Abstract Cerebral vasculitis represents a rare form of vascular inXammatory involvement caused by heterogeneous conditions. In this study, the wide spectrum of cerebral vasculitis despite primary angiitis of the CNS is analyzed. Our cohort included 16 white patients with cerebral vasculitis treated in a single German institution between 2003 and 2008. Clinical and diagnostic features were obtained by retrospective chart review; follow-up information and outcome were obtained prospectively.
Introduction
Most strokes are attributed to arteriosclerosis or brain embolism. As an uncommon cause of stroke or cerebral inXammation, cerebral vasculitis may be considered. Primary central nervous system vasculitis, also known as primary or isolated angiitis of the central nervous system (PCNSV), is often considered in the diagnosis of cerebral vasculitis [3] . But what conditions despite PCNSV are responsible for cerebral vasculitis? These aZictions remain poorly recognized. Heterogeneity of the disease is responsible for a lack of uniform diagnostic criteria and treatment recommendations. Our existing knowledge is based on incompatible and small case series or single case reports [3] . Cerebral vasculitis is still a major diagnostic and therapeutic challenge and is magniWed by numerous unanswered questions regarding epidemiology, predisposition, pathophysiology and outcome. As we frequently are asked to re-evaluate patients with uncommon causes of stroke, we had the opportunity to evaluate 16 patients with cerebral vasculitis despite PCNSV treated within a short period of 5 years.
Materials and methods

Patient selection
Sixteen consecutive patients diagnosed with cerebral vasculitis from 2003 through 2008 in the Alfried-Krupp Hospital, Essen, Germany, were recruited in this study. We excluded 21 patients in whom PCNSV was diagnosed and patients in whom the diagnosis of CNS vasculitis was not deWnite. Patients with systemic vasculitis without CNS involvement were also excluded from this analysis.
Clinical data collection
In living patients diagnosed >1 year before data collection, we tried to obtain follow-up information by telephone interview or from outside hospital charts. In living patients diagnosed <1 year before data collection, the requested features were obtained from recent clinical visits. Evaluation was focused on demographic, clinical and outcome features. Analysis included demographic data such as sex and age at the Wrst cerebral symptom presentation, clinical presentation at onset of disease and during follow-up period, and results from MRI, angiography, CNS biopsy and laboratory investigations. Furthermore, treatment data were collected. Functional status at Wrst visit and latest follow-up was classiWed by using the modiWed Rankin score (MRS).
Statistics and data analysis
Statistical analysis was completed with SPSS version 17.0. Statistical comparisons of categorical information were done using Chi-quadrate test or Fisher's exact test when samples were small. Comparisons were made using the Mann-Whitney U test (Wilcoxon test) for numeric data. P < 0.05 was considered to be statistical signiWcant, and P < 0.06 was regarded as a trend to signiWcance. All P values were two sided.
Results
Demographic data and diagnosis
The heterogeneous group of patients included ten patients with primary vasculitis. There were seven cases of Behçet syndrome and one case each of giant cell arteritis, Wegener's granulomatosis or Churg-Strauss syndrome, respectively. Vasculitides secondary to systemic disease were diagnosed in two patients with systemic lupus erythematosus, one patient with sarcoidosis and one patient with ANA-positive systemic vasculitis. Two patients presented with infectious angiitis due to borreliosis and syphilis.
The mean age of the 16 patients at the time of cerebral symptom onset was 41.38 years (median 39 years, range 27-70 years). The mean age at cerebral symptom onset of the seven patients with Behçet syndrome was 37.43 years (median 33 years, range 27-55 years) and that of the nonBehçet patients was 44.44 years (median 42.0 years, range 35-70 years). The gender distribution of all patients was 1:1; males with Behçet syndrome were more frequent (71.4%), and females were more frequently non-Behçet patients (66.7%). One patient was of Spanish, four of Turkish or Kurdish (25.0%) and 11 (68.8%) of German family origin. All patients with Turkish or Kurdish family origin had Behçet syndrome, and so 57.1% of all patients with Behçet syndrome had Turkish or Kurdish ancestors. The mean follow-up period was 54.5 months (median 22.5 months, range 1-240 months). There was a statistically signiWcant diVerence with a longer follow-up in patients with Behçet syndrome (mean 102.71 months, median 120 months, range 1-240 months) compared with non-Behçet patients (mean 17 months, median 7 months, range 2-75 months) (P = 0.031). Cerebrovascular risk factors were present in 6 of 16 patients (37.5%), which were smoking in Wve (31.3%) and arterial hypertension in three patients (18.8%). There was no statistical diVerence regarding age, sex and frequency of cerebrovascular risk factors in patients with or without Behçet syndrome. Cerebrovascular risk factors were not related to the frequency of strokes, transient ischemic attacks, microangiopathy or diVusion disturbances in MRI, or death.
Clinical symptoms
The clinical presentation of CNS vasculitis was highly variable. The most frequent clinical symptoms over the whole follow-up period were headache (56.3%), gait disturbances (62.5%) and unilateral numbness of the body (50%). Clinical symptoms at onset of disease were similar to clinical features during follow-up. Ischemic events such as stroke or transient ischemic attack were infrequent (37.5%). None of the patients with Behçet syndrome experienced an ischemic event, which was a signiWcant diVerence compared with the other patients (P = 0.011). One patient with Behçet syndrome presented with recurring aseptic meningitis. Almost all patients with Behçet syndrome suVered from headaches, which represented a signiWcant diVerence compared to the other vasculitis patients (P = 0.011) during the follow-up period and a trend toward signiWcance (P = 0.06) in the whole observation period. None of the patients characterized headache as "thunderclap" headache.
Only one patient (the one with Wegener's granulomatosis) experienced an intracerebral hemorrhage. There was no other statistical diVerence in cerebral symptoms observable between patients with Behçet syndrome and the other vasculitis patients. However, as the group of patients had cerebral vasculitis due to diVerent underlying conditions, they widely diVered in their additional systemic symptoms.
The patient with Wegener's granulomatosis showed cerebral vasculitis with repeated intraparenchymal hemorrhages in a late stage of the disease (25 years after the Wrst systemic symptoms). No other reasons (medication side eVect or coagulation disturbances) for neurological symptoms despite vasculitis were found. She also showed mixed axonal and demyelinating polyneuropathy, symptomatic seizures and reactive depression. Furthermore, she suVered from chronic sinusitis and serious lung and kidney involvement with pulmonary bleedings, secondary glomerulonephritis with dialysis and kidney transplantation. In the two female patients with systemic lupus erythematosus (SLE), one presented with cognitive decline, hemiparesis, symptomatic seizures and interstitial myositis due to biopsy-proven vasculitis more than 20 years after the retrospectively described onset of systemic symptoms, but which was Wrst diagnosed at that time. Her history was signiWcant for livedo racemosa, chronic polyarthritis and two spontaneous abortions (without evidence of antiphospholipid antibody syndrome). The other patient with systemic lupus erythematosus had a history of pericarditis and polyarthritis and presented with cerebral vasculitis 14 years after the establishment of diagnosis. In the patient with cerebral vasculitis due to sarcoidosis, stage IV symptoms included kidney insuYciency with IgA nephritis and interstitial nephritis, atrioventricular block and anemia. The patient with cerebral vasculitis due to Churg-Strauss syndrome with repeated transient ischemic attacks also showed polyneuropathy with histological detection of small vessel vasculitis. Further clinical hallmarks in this patient were allergic diathesis, asthma and sinusitis. In this patient, diagnosis of Churg-Strauss syndrome was not established until neurological symptoms appeared. In the seven patients with Behçet syndrome, all presented with recurrent aphthous stomatitis, four patients (57.1%) with genital ulcerations, three (42.8%) with eye lesions (uveitis, retinal vasculitis, optic nerve neuritis, retinal periphlebitis) and three (42.8%) with skin lesions (folliculitis, erythema nodosum). Only two patients showed positive pathergy testing, but the other tests were partly performed after the initiation of immunosuppressive treatment. Despite mucocutaneous signs, only three patients with eye involvement consulted a health-care consultant earlier. In the others, Behçet syndrome was not diagnosed until neurological involvement occurred. In the patient with ANA-positive cerebral vasculitis and in the two patients with infectious vasculitis due to syphilis and borreliosis, no other systemic symptoms were detectable. Our male patient with giant cell angiitis suVered from bitemporal headaches and fever for 2 weeks before stroke.
Magnetic resonance Wndings
MRI was performed and revealed abnormal Wndings in all patients (100%). Ischemic infarctions were the most frequently observed signs in MRI in the group of patients with vasculitis without Behçet syndrome (77.8%), while no patient with Behçet syndrome presented with infarctions in MRI (P = 0.003). In contrast, gadolinium-enhancing lesions were signiWcantly more frequent in Behçet syndrome (85.7%) compared with the other types of vasculitis (22.2%) (P = 0.041). Signs of microangiopathy were also frequently observed on MRI (56.3% for all, 42.9% in Behçet syndrome, 66.7% in non-Behçet vasculitides, respectively). Almost all patients showed bilateral MRI abnormalities (81.3%).
Conventional cerebral angiography
Conventional cerebral angiography was carried out in 6 of 15 documented patients (40%). Almost all of them were performed in non-Behçet syndrome patients. Five of eight patients with cerebral vasculitis due to other causes despite Behçet syndrome underwent angiography (62.5%), which was indicative for vasculitis in all of them. In one patient diagnosed as having Behçet syndrome, an old carotid artery dissection was evident on angiography. A few days after an angiogram, ICA dissection of the other side appeared without documented complications in the course of angiography or any adequate trauma.
Histological features
CNS biopsy was performed in only 2 of 15 documented patients (13.3%). Histopathological examinations revealed the deWnite diagnosis of cerebral vasculitis in both cases. A peripheral biopsy was histological analyzed in 5 of 15 documented cases (33.3%) and documented vasculitis in all four vasculitis patients with non-Behçet syndrome.
Laboratory and cerebrospinal Xuid studies In 13 of 16 patients (81.3%), CSF examinations were performed and disclosed abnormal Wndings (cell count >5 cells/ l or total protein concentration >45 mg/dl) in 12 of them (92.3%). Samples were obtained in all seven patients with Behçet syndrome and were indicative of inXammation in all of them. In the other patients, Wve of six examinations (83.3%) revealed pathological results. The typical Wnding in CSF was a mild lymphocytic pleocytosis combined with an elevated protein level. The mean cell count was 51.27/ l (median 28/ l, range 7-148/ l), and the mean concentration of total protein was 133.4 mg/dl (median 73.0 mg/dl, range 56-317 mg/dl). There was no signiWcant diVerence between patients with and without Behçet syndrome regarding cell count and protein level. Oligoclonal banding was found in 33.3% of patients (33.3% in Behçet syndrome, 33.3% in non-Behçet syndrome). Laboratory screening was unremarkable for complement factors C3 and C4, antinuclear antibodies, antibodies to extractable nuclear antigens, antineutrophil cytoplasmic antibodies and HIV in all patients with Behçet syndrome. Antinuclear antibodies, rheumatic factors, antibodies to extractable nuclear antigens and antineutrophil cytoplasmic antibodies were partly elevated in the other vasculitis patients.
Treatments
Thrombocyte antiaggregation drugs were prescribed in 4 of 16 patients (25%). An immunosuppressive therapy was documented in the grand majority of patients (81.3%). In detail, these included intravenous glucocorticoid therapy in 62.2%, oral glucocorticoid therapy in 56.4%, intravenous and/or oral cyclophosphamide in 18.8% and azathioprin in 37.5% of the patients. The two patients with cerebral vasculitis due to infectious diseases (neurosyphilis and borreliosis) were treated with antibiotic drugs. A positive response to therapy was noted in 15 of 16 patients (93.3%). There was a statistically signiWcant diVerence observable in patients with Behçet syndrome compared with the other vasculitis patients regarding the higher incidence of azathioprin treatment in Behçet syndrome (71.4 vs. 11.1%, P = 0.043). No biological agents were given in this series of patients.
Outcome
Complications of treatment or diagnostic procedures were recognized over the course of the disease in 4 of 16 cases (20%). As mentioned before, one patient diagnosed with Behçet syndrome experienced ICA dissection after angiography without adequate trauma. The patient with sarcoidosis acquired a lung aspergillosis associated with immunosuppression. After paused immunosuppression due to treatment of aspergillosis sarcoidosis, her condition worsened with new aVection of cerebral vessels. Two patients died within the documented follow-up. Both of them had systemic diseases with cerebral manifestation (Wegener's granulomatosis and sarcoidosis) with serious organ involvement (kidney and lung) and died due to noncerebral disease progression. ModiWed Rankin disability scores were assessed at Wrst presentation and at the last follow-up examination. Median MRS was 1 (mean 1.47; range 0-4) at the Wrst presentation and 1 (mean 1.67; range 0-6) at the last visit. There was no signiWcant diVerence between the vasculitis patients with or without Behçet syndrome.
Discussion
Cerebral vasculitis is a heterogeneous disease in which inXammation is caused by a wide range of causes. This analysis was focused on patients in whom cerebral vasculitis was not diagnosed as "isolated angiitis of the CNS" (also called "primary angiitis of the CNS"). The spectrum of diVerential diagnosis includes primary systemic vasculitides, vasculitis in collagen vascular diseases, infectious vasculitis, vasculitis associated with neoplasia and vasculitis associated with drug abuse or treatment. The clinical presentation of cerebral vasculitis is highly variable; the diVerential diagnostic considerations are numerous.
It is interesting that Behçet syndrome is the most frequent cause for cerebral vasculitis in our cohort. Despite the possibility of referring bias in the Rhine-Ruhr area with a great part of the population with Turkish or Kurdish ancestors, it is important to consider in the diVerential diagnosis even patients without Mediterranean family origin. In our cohort, the ethnic background of four of seven Behçet patients (57.1%) was Turkish or Kurdish, while the remaining 42.8% were Germans. Behçet syndrome is a multisystemic vasculitis of the small-sized vessels. Venous involvement is typical in Behçet syndrome and arterial participation is extremely rare. Neurological involvement may occur within the nervous parenchyma (neuro-Behçet) or in the cerebral vascular system (vasculo-Behçet) with a great incidence of cerebral sinus and venous thrombosis [14] . In our cohort, all but one patient suVered from parenchymal neuro-Behçet and one patient showed recurrent aseptic meningitis. One patient presented with very rare arterial involvement with arterial dissections [2] . Neuro-Behçet begins months or years after the mucocutaneous manifestations. As seen in our patients, often neurological involvement can also be the Wrst occasion for consulting health-care consultants. Another diagnostic challenge may be the mild or incomplete mucocutaneous presentation. Meningoencephaltis predominates in the brainstem and is characterized by a variety of symptoms including headache [7] . In our cohort, none of the patients with Behçet syndrome presented with MR tomographic signs of infarction, but showed signiWcant more gadolinium-enhancing lesions. As the diagnosis of neuro-Behçet is entirely based on clinical grounds, this disease is the only type of cerebral vasculitis in which cerebral angiography and CNS biopsy are not required. Cerebral arterial manifestations such as aneurysms and arterial dissections are extremely rare in this venous vasculitis. In the aVected arteries, active arteritis occurs initially, followed by destruction of the media and Wbrosis [2, 7] . Cerebrospinal Xuid studies showed pleocytosis and infrequent oligoclonal bandings. The absence of more than two oligoclonal immunoglobulin G bands was referred as indicative of neuro-Behçet in the diVerential diagnosis to multiple sclerosis. But, the number of patients (33.3%) with positive oligoclonal bands in our cohort once more demonstrates the diYculties in diagnosis. Whether the substances used for the mucocutaneous manifestations also are eVective in treating CNS manifestations has not been studied in larger trials. In neuro-Behçet, combinations of high doses of corticoids and immunosuppressive drugs are recommended. Cyclosporin A should not be used in the treatment of neuro-Behçet patients because of its potential neurotoxicity [6] . In our cohort, patients with Behçet syndrome were often treated with azathioprin. There was no signiWcant diVerence in outcome features between patients with Behçet syndrome and those with other vasculitis.
Our cohort included also one patient with histologically proven cerebral giant cell arteritis. Brain infarction is a well-recognized complication of temporal arteritis, but may also be the initial presentation of temporal arteritis. Color duplex sonography showed stenosis of the MCA-M1 segment on both sides. His cerebral angiography revealed the typical picture of cerebral vasculitis in the peripheral arteries, predominantly in the MCA of both sides. Laboratory investigations showed mild elevated C-reactive protein and almost normal ESR. Cerebrospinal Xuid studies showed pleocytosis (115 cells/ l) and mild elevated total protein (72.4 mg/dl). Brain biopsy showed giant cell arteritis. Color duplex sonography of temporal artery performed after receiving this result demonstrated typical dark halo indicative of temporal vasculitis. This case is very elucidating because it shows how important it is to think of giant cell arteritis even in uncommon cases. In this patient, a temporal duplex sonography performed earlier would have prevented invasive procedures such as cerebral angiography and brain biopsy. However, this case is exceptional because of the young age of the patient, the almost normal ESR and the intracranial vessel involvement. All these facts are extremely rare, but have been reported [8, 10, 16] . Approximately, 4% of patients with temporal arteritis experience transient ischemic attacks or strokes. The posterior circulation is the classical territory for strokes due to temporal arteritis; extracranial vertebral arteries are commonly aVected [12] .
Another extremely rare cause of cerebral vasculitis is Churg-Strauss syndrome (CSS). CSS typically presents with allergic diathesis, asthma and polyneuropathies of the multiplex type [9] . Our male patient presented with biopsyproven peripheral involvement, but showed also cerebral vasculitis with transient ischemic attacks. In a case series by Sehgal et al. [13] , brain infarcts were seen in 3 of 47 patients. There are few other case reports on CNS involvement of CSS [9, 17] .
Another patient presented with cerebral hemorrhage due to vasculitis in a severe case of WegenerЈs granulomatosis. As in this patient, neurological symptoms typically occur in the stage of generalization. This patient died due to systemic progression of the disease. The other patient who died due to systemic disease progression and treatment of complications was the patient with severe systemic sarcoidosis. CNS involvement occurs in approximately 5% of patients with sarcoidosis [11, 15] . The most common neurological manifestations of sarcoidosis are cranial neuropathies (50-75%) and parenchymal involvement (overall 50%) [11] . Stroke is, however, an exceedingly rare complication of neurosarcoidosis, with very few case reports in literature. Mechanisms responsible for stroke in sarcoidosis may be in situ thrombosis from perivascular granulomatous inXammation, cardiogenic emboli, large-artery compression or artery-to-artery emboli [11, 15] . Occurrence of angiitis as demonstrated in our patient has been reported as extremely rare [4] .
Our cohort included two patients with cerebral vasculitis due to SLE and one patient with ANA-positive vasculitis not fulWlling SLE criteria. SLE is generally considered in the evaluation of stroke in young patients [1] . SLE is a relatively uncommon etiology of stroke, even in young persons, being found in only 3.5% of stroke patients before the age of 45 years [1] . True vasculitis is an overestimated association in patients with stroke in SLE. Careful evaluation for cardiogenic emboli, hypercoagulable states and artherosclerosis should be performed. In SLE, strokes are often caused by a secondary antiphospholipid syndrome. In our experience, most patients referred to us do not have true cerebral vasculitis in SLE.
Our cohort also included two patients with cerebral vasculitis due to infectious diseases. The incidence of strokes in meningovascular syphilis is reported to range from 7 to 23% [5] . The cause of most cerebrovascular diseases is syphilitic endarteritis. The middle cerebral artery is the most commonly involved vessel leading to stroke [5] . In our patient, occlusion of the left PCA was documented in angiography. The other patient with vasculitis due to infectious disease had neuroborreliosis. Since the Wrst description of meningovascular neuroborreliosis in 1987, reports of at least another 32 patients with meningovascular neuroborreliosis have appeared [5] . As in SLE, in clinical practice, neuroborreliosis is widely overestimated since it is extremely rare in the diVerential diagnosis of uncommon strokes and true vasculitis.
In conclusion, the spectrum of diVerential diagnosis includes a wide range of diseases. As cerebral vasculitis is a heterogeneous group of disorders, the clinical presentations can be highly variable and diVerent diagnostic approaches are necessary. Cerebral angiography and brain biopsy are the diagnostic gold standard in cerebral vasculitis, but in Behçet syndrome these are not required. In some types of systemic vasculitis, a muscle and nerve biopsy can reveal the diagnosis and so brain biopsy is not obligatory.
However, in these cases, it is important to consider if cerebral involvement is really caused by the systemic disease and to exclude other possible origins such as medication side eVects, coagulation disturbances or arteriosclerosis.
Our investigation has a number of limitations. Most of the data were assessed retrospectively, since the prospective follow-up was incomplete. The possibility of referral bias has to be calculated. Our investigation is lucid and valuable, because it represents one of the most detailed descriptions of European patients with cerebral vasculitis from a single center.
The strength of our study is the large number of consecutive patients treated over the short period of 5 years. A further strong point in our analysis is the attempt to measure prospective data. Furthermore, this study clearly points to the remaining deWcits in knowledge of the disease. To date, it is still a challenge to diagnose, treat and follow up patients suspected of cerebral vasculitis. Due to the missing clinical guidelines and the rarity of these diseases, diagnosis and treatment should be reserved to centers with great expertise in vasculitis. Furthermore, the complex nature of the disease requires an intensive multiprofessional approach with good cooperation of neurological, rheumatologic, neurosurgical and neuroradiological experts in this Weld. To solve some aspects of its enigma, a prospective, multicenter, collaborative study including recent patients suspected to have cerebral vasculitis, as demanded by Berlit [3] , is urgently needed.
